The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Low-dose chemotherapy with methotrexate and vinblastine for patients with refractory desmoid tumors: A second report of relationship between efficacy and various factors.
 
Yoshihiro Nishida
Consulting or Advisory Role - Kaken Pharmaceutical
Speakers' Bureau - Chugai Pharma; Daiichi Sankyo; Ono Pharmaceutical
Research Funding - Daiichi Sankyo; Pfizer
 
Tomohisa Sakai
No Relationships to Disclose
 
Koki Shimizu
No Relationships to Disclose
 
Hiroshi Urakawa
No Relationships to Disclose
 
Eisuke Arai
No Relationships to Disclose
 
Kunihiro Ikuta
No Relationships to Disclose
 
Yuichi Ando
Honoraria - AstraZeneca; Bayer Holding; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Kyowa Hakko Kirin; Lilly; Merck Serono; Mochida Pharmaceutical Co. Ltd.; Nippon Kayaku; Novartis; Novartis; Ono Pharmaceutical; Sawai Pharmaceutical Co; Shionogi; Taiho Pharmaceutical; Tsumura & Co.; Yakult Honsha
Consulting or Advisory Role - ICON Clinical Research; Kowa; Ono Pharmaceutical; SymBio Pharmaceuticals
Research Funding - Chugai Pharma; Daiichi Sankyo; Eisai; Kyowa Hakko Kirin; Lilly; Mochida Pharmaceutical Co. Ltd.; Nippon Kayaku; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha
 
Naoki Ishiguro
Consulting or Advisory Role - Ono Pharmaceutical
Speakers' Bureau - Astellas Pharma; Bristol-Myers Squibb; Daiichi Sankyo; Lilly Japan; Pfizer; Taisho Pharmaceutical Holdings
Research Funding - Abbvie (Inst); Asahi Kasei (Inst); Astellas Pharma (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Kaken Pharmaceutical (Inst); Mitsubishi Tanabe Pharma (Inst); Otsuka (Inst); Pfizer (Inst); Takeda (Inst); Zimmer Biomet (Inst)